Equity Valuation and Portfolio Management
Autor: | Frank J. Fabozzi, Harry M. Markowitz |
---|---|
EAN: | 9781118156537 |
eBook Format: | |
Sprache: | Englisch |
Produktart: | eBook |
Veröffentlichungsdatum: | 20.09.2011 |
Kategorie: | |
Schlagworte: | Frank Fabozzi Harry Markowitz classic portfolio strategies equity valuation equity valuation and portfolio management equity valuation process fundamental analysis modern po new portfolio strategies portfolio management valuing stock prices |
60,99 €*
Versandkostenfrei
Die Verfügbarkeit wird nach ihrer Bestellung bei uns geprüft.
Bücher sind in der Regel innerhalb von 1-2 Werktagen abholbereit.
Equity valuation is a method of valuing stock prices using fundamental analysis to determine the worth of the business and discover investment opportunities.
In Equity Valuation and Portfolio Management Frank J. Fabozzi and Harry M. Markowitz explain the process of equity valuation, provide the necessary mathematical background, and discuss classic and new portfolio strategies for investment managers. Divided into two comprehensive parts, this reliable resource focuses on valuation and portfolio strategies related to equities.
- Discusses both fundamental and new techniques for valuation and strategies
- Fabozzi and Markowitz are experts in the fields of investment management and economics
- Includes end of chapter bullet point summaries, key chapter take-aways, and study questions
Filled with in-depth insights and practical advice, Equity Valuation and Portfolio Management will put you in a better position to excel at this challenging endeavor.
FRANK J. FABOZZI, PHD, CFA, is Professor of Finance at EDHEC Business School and a member of the EDHEC-Risk Institute. Prior to joining EDHEC in August 2011, he held various professorial positions in finance at the Yale School of Management from 1994 to 2011 and was a visiting professor of finance and accounting at the MIT Sloan School of Management from 1986 to 1992. He is also Editor of the Journal of Portfolio Management.
HARRY M. MARKOWITZ, PHD, is President of Projections Research Inc., a consulting company offering pharmacokinetic and pharmacometric services, and the founder of Baysient LLC, a company that develops systems to individualize doses of drugs that are difficult to manage.